FDA Approves New Cholesterol-Lowering Drug The U.S. Food and Drug
FDA Approves New Cholesterol-Lowering Drug
The U.S. Food and Drug Administration today approved the 4 milligram maximum dose of Livalo (pitavastatin), a drug intended to improve blood cholesterol levels in persons with elevated or abnormal blood cholesterol levels.